These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3861896)
1. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. McGuire WL; Dressler LG J Natl Cancer Inst; 1985 Sep; 75(3):405-10. PubMed ID: 3861896 [No Abstract] [Full Text] [Related]
2. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328 [TBL] [Abstract][Full Text] [Related]
3. DNA and cell cycle analysis as prognostic indicators in breast tumors revisited. Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Wright S; Baldetorp B Clin Lab Med; 2001 Dec; 21(4):875-95, x. PubMed ID: 11770293 [TBL] [Abstract][Full Text] [Related]
4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
5. DNA analysis in advanced breast cancer. Leivonen M; Krogerus L; Nordling S Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211 [TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometric measurements in breast cancer: a review of the instrumentation principles and clinical significance. Berho M; Viciana AL; Poppiti RJ; Ruiz P J Fla Med Assoc; 1997 Feb; 84(2):104-10. PubMed ID: 9066236 [TBL] [Abstract][Full Text] [Related]
8. [Cytology and cytometry of breast cancer]. Feichter GE; Dalquen P; Oberholzer M Ther Umsch; 1993 May; 50(5):299-306. PubMed ID: 8378885 [TBL] [Abstract][Full Text] [Related]
9. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
10. Prediction of relapse in patients with breast cancer by DNA cytometry. Machado-Santelli GM; Mori L; Pereira CA Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156 [TBL] [Abstract][Full Text] [Related]
11. [Flow cytophotometry DNA analysis and immunohistologic determination of the proliferation behavior of breast cancer and proliferating mastopathy]. Mellin W; Vollmer E; Nienhaus H; Grundmann E Verh Dtsch Ges Pathol; 1985; 69():540-3. PubMed ID: 2869624 [No Abstract] [Full Text] [Related]
12. [Long-term survival in terms of DNA-RNA contents in breast cancer]. Hara S; Kondo M; Tagawa Y; Itoyanagi N; Kishimoto K; Matuo S; Akamine S; Takahashi T; Oka T; Ayabe H Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():422-5. PubMed ID: 9589046 [TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and TLI in association with other prognostic parameters in breast cancer. Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometry in oncology: a review with emphasis on DNA flow cytometry in human solid tumours. Blijham GH; Schutte B Neth J Med; 1983; 26(10):314-20. PubMed ID: 6361591 [No Abstract] [Full Text] [Related]
16. [Relationship between DNA ploidy and survival in breast cancer]. Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048 [TBL] [Abstract][Full Text] [Related]
17. Prognostic markers in node-negative breast cancer: a prospective study. Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy. Michels JJ; Duigou F; Marnay J; Denoux Y; Delozier T; Chasle J Cytometry B Clin Cytom; 2003 Sep; 55(1):37-45. PubMed ID: 12949958 [TBL] [Abstract][Full Text] [Related]
19. [Use of laser flow cytometry in the study of fibrocystic mastopathy and breast cancer]. Bogatyrev VN; Kupin VI; Polevaia EB Lab Delo; 1983; (9):16-8. PubMed ID: 6195424 [No Abstract] [Full Text] [Related]
20. Evaluation of DNA content and proliferative activity in prediction of short-term relapses in mammary carcinoma: a prospective study. Lackowska B; Niezabitowski A; Ryś J; Skołyszewski J; Stelmach A; Sokołowski A; Gruchała A; Jaszcz-Gruchała A; Markiewicz D Pol J Pathol; 1999; 50(3):139-44. PubMed ID: 10624115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]